|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sholl LM: The molecular pathology of lung
cancer. Surg Pathol Clin. 9:353–378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mao Y, Yang D, He J and Krasna MJ:
Epidemiology of lung cancer. Surg Oncol Clin N Am. 25:439–445.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Puri T: Targeted therapy in nonsmall cell
lung cancer. Indian J Cancer. 54:83–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jathar S, Kumar V, Srivastava J and
Tripathi V: Technological developments in lncRNA biology. Adv Exp
Med Biol. 1008:283–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jarroux J, Morillon A and Pinskaya M:
History, discovery, and classification of lncRNAs. Adv Exp Med
Biol. 1008:1–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A New Paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Sharma S and Watabe K: Roles of
lncRNA in breast cancer. Front Biosci (Schol Ed). 7:94–108. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thin KZ, Liu X, Feng X, Raveendran S and
Tu JC: LncRNA- DANCR: A valuable cancer related long non-coding RNA
for human cancers. Pathol Res Pract. 214:801–805. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balas MM and Johnson AM: Exploring the
mechanisms behind long noncoding RNAs and cancer. Noncoding RNA
Res. 3:108–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qi G, Kong W, Mou X and Wang S: A new
method for excavating feature lncRNA in lung adenocarcinoma based
on pathway crosstalk analysis. J Cell Biochem. 120:9034–9046. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng W, Wang J, Shan B, Peng Z, Dong Y,
Shi W, He D, Cheng Y, Zhao W, Zhang C, et al: Diagnostic and
prognostic potential of circulating long non-coding RNAs in non
small cell lung cancer. Cell Physiol Biochem. 49:816–827. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dai SP, Jin J and Li WM: Diagnostic
efficacy of long non-coding RNA in lung cancer: A systematic review
and meta-analysis. Postgrad Med J. 94:578–587. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan X, Zheng G and Gao C: LncRNA PVT1: A
novel therapeutic target for cancers. Clin Lab. 64:655–662. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song P, Jiang B, Liu Z, Ding J, Liu S and
Guan W: A three- lncRNA expression signature associated with the
prognosis of gastric cancer patients. Cancer Med. 6:1154–1164.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao Z, Zhang W and Dong D: A potential
prognostic lncRNA signature for predicting survival in patients
with bladder urothelial carcinoma. Oncotarget. 8:10485–10497. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN,
Zhang JY, Liu C and Qu K: Six-long non-coding RNA signature
predicts recurrence-free survival in hepatocellular carcinoma.
World J Gastroenterol. 25:220–232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo D, Deng B, Weng M, Luo Z and Nie X: A
prognostic 4-lncRNA expression signature for lung squamous cell
carcinoma. Artif Cells Nanomed Biotechnol. 46:1207–1214. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu T, Wang Y, Chen D, Liu J and Jiao W:
Potential clinical application of lncRNAs in non-small cell lung
cancer. Onco Targets Ther. 11:8045–8052. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miao R, Ge C, Zhang X, He Y, Ma X, Xiang
X, Gu J, Fu Y, Qu K, Liu C, et al: Combined eight-long noncoding
RNA signature: A new risk score predicting prognosis in elderly
non-small cell lung cancer patients. Aging (Albany NY). 11:467–479.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Li B, Ran P and Wang L:
Identification of ceRNA network based on a RNA-seq shows prognostic
lncRNA biomarkers in human lung adenocarcinoma. Oncol Lett.
16:5697–5708. 2018.PubMed/NCBI
|
|
24
|
Kumar P, Khadirnaikar S and Shukla SK: A
novel LncRNA- based prognostic score reveals TP53-dependent subtype
of lung adenocarcinoma with poor survival. J Cell Physiol. Feb
10–2019.doi: 10.1002/jcp.28260 (Epub ahead of print). View Article : Google Scholar
|
|
25
|
Songyang Y, Zhu W, Liu C, Li LL, Hu W,
Zhou Q, Zhang H, Li W and Li D: Large-scale gene expression
analysis reveals robust gene signatures for prognosis prediction in
lung adenocarcinoma. PeerJ. 7:e69802019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li YY, Yang C, Zhou P, Zhang S, Yao Y and
Li D: Genome-scale analysis to identify prognostic markers and
predict the survival of lung adenocarcinoma. J Cell Biochem.
119:8909–8921. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang PH: Asymptotics of AIC, BIC, and
RMSEA for model selection in structural equation modeling.
Psychometrika. 82:407–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sing T, Sander O, Beerenwinkel N and
Lengauer T: ROCR: Visualizing classifier performance in R.
Bioinformatics. 21:3940–3941. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang DW, Sherman BT, Tan Q, Kir J, Liu D,
Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA:
DAVID bioinformatics resources: Expanded annotation database and
novel algorithms to better extract biology from large gene lists.
Nucleic Acids Res. 35:W169–W175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu J, Mao X, Cai T, Luo J and Wei L: KOBAS
server: A web-based platform for automated annotation and pathway
identification. Nucleic Acids Res. 34:W720–W724. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Merico D, Isserlin R, Stueker O, Emili A
and Bader GD: Enrichment map: A network-based method for gene-set
enrichment visualization and interpretation. PLoS One.
5:e139842010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ito K and Murphy D: Application of ggplot2
to pharmacometric graphics. CPT Pharmacometrics Syst Pharmacol.
2:e792013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Forrest ME and Khalil AM: Review:
Regulation of the cancer epigenome by long non-coding RNAs. Cancer
Lett. 407:106–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schmitz SU, Grote P and Herrmann BG:
Mechanisms of long noncoding RNA function in development and
disease. Cell Mol Life Sci. 73:2491–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and
Chen Y: Long non-coding RNA: A new player in cancer. J Hematol
Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen W, You J, Zheng Q and Zhu YY:
Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma
progression by AKT/mTOR and Wnt/β-catenin signaling pathways.
Cancer Manag Res. 10:1817–1826. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lv Y, Chen S, Wu J, Lin R, Zhou L, Chen G,
Chen H and Ke Y: Upregulation of long non-coding RNA OGFRP1
facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis
and by activating PI3K/AKT/GSK-3beta pathway. Artif Cells Nanomed
Biotechnol. 47:2083–2090. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tang LX, Chen GH, Li H, He P, Zhang Y and
Xu XW: Long non-coding RNA OGFRP1 regulates LYPD3 expression by
sponging miR-124-3p and promotes non-small cell lung cancer
progression. Biochem Biophys Res Commun. 505:578–585. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ferré F, Colantoni A and Helmer-Citterich
M: Revealing protein-lncRNA interaction. Brief Bioinform.
17:106–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Joerger AC and Fersht AR: The p53 pathway:
Origins, inactivation in cancer, and emerging therapeutic
approaches. Annu Rev Biochem. 85:375–404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
